Patents Assigned to SunnyBay Bio Tech, Inc.
  • HERV-K Antibody Therapeutics
    Publication number: 20240059787
    Abstract: The invention provides therapeutic humanized anti-HERV-K antibodies, CAR, or a fusion thereof consisting of a hispecific T ceil engager (BiTE) FOR CD3 and CDS, a DNA-encoded BiTE (DBiTE), or an antibody-drug conjugate (ADC). The invention also relates to peptides, proteins, nucleic acids, and cells for use in immunotherapeutic methods. In particular, the invention relates to the immunotherapy of cancer peptides bound to molecules of the MHC, or peptides as such, which can also be targets of antibodies and other binding molecules.
    Type: Application
    Filed: September 18, 2021
    Publication date: February 22, 2024
    Applicant: SunnyBay Bio Tech, Inc.
    Inventors: Feng Wang-Johanning, Gary Johanning
  • ENDOGENOUS RETROVIRUSES FOR THE DETECTION, DIAGNOSIS, AND PROGNOSIS OF CANCER
    Publication number: 20230258643
    Abstract: The invention provides for the early detection, diagnostic, and prognostic assays and assay kits for breast cancer and other cancers, based upon the detection of human endogenous retroviruses (HERVs) as cancer biomarkers.
    Type: Application
    Filed: April 9, 2021
    Publication date: August 17, 2023
    Applicant: SunnyBay Bio Tech, Inc.
    Inventors: Gary JOHANNING, Feng WANG-JOHANNING